Welcome to Dermbits! Watch short videos of KOLs answering your questions

thumbnail_dermbits-colorful.png

dermbits-colorful.png

Dermbits

What was the baseline SALT score for patients included in the BRAVE-AA1 and BRAVE-AA2 trials?

Alopecia

You. So the salt score, the severity of alopecia. It's the tool used to evaluate the extent of scalp hair loss in the study. Essentially, that salt score number. So to get into the study had to be an adult with severe alopecia, defined as at least 50 on the salt score. That equates to 50% scalp hair loss. So that was the entry level into the study. To be considered an endpoint success at week 36, they had to get to a salt score of 20 or less. That means the 20% or less scalp hair loss when you're looking at them at that point in time. So those were the criteria as far as both of the phase three trials.